EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Intravitreal Application of Mesenchymal Stem Cell By-Products Does Not Ameliorate Experimental Autoimmune Uveitis

Eva Uherková, Kateřina Palacká, Eva Škrlová, Barbora Heřmánková, Aneta Klímová, Petra Svozílková, Vladimír Holáň, Jarmila Heissigerová

Folia Biologica · 2026 · 72 (2) · 95-108

DOI: 10.14712/fb2026.0010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Folia Biologica, online erschienen am 29.04.2026. Verfasst von Eva Uherková und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic. Hauptthemen laut MEDLINE: Uveitis, Mesenchymal Stem Cells, Autoimmune Diseases, Mesenchymal Stem Cell Transplantation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Grantová Agentura, Univerzita Karlova, Univerzita Karlova v Praze, Ministerstvo Zdravotnictví Ceské Republiky.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The study aimed to evaluate the therapeutic effects of mesenchymal stem cells and their by-products, including conditioned medium, extract and exosomes, on intraocular inflammation in experimental autoimmune uveitis. Uveitis was induced in the C57BL/6J mouse strain by administration of interphotoreceptor retinoid-binding protein, complete Freund’s adjuvant and pertussis toxin. Mesenchymal stem cell-derived products (conditioned medium, extract and exosomes) were prepared and administered intravitreally at varying time points post-induction, primarily on day 14. Retinal inflammatory changes were monitored using fundus imaging, flow cytometry and RT-PCR analysis to evaluate clinical manifestation of inflammation, immune cell infiltration and gene expression of inflammatory markers. In vivo, administration of mesenchymal stem cell by-products did not ameliorate experimental autoimmune uveitis. On the contrary, treated eyes exhibited exacerbated inflammation, including increased immune cell infiltration and up-regulated pro-inflammatory gene expression (e.g., Gfap , Iba1 , Il1b and Il17 ). In vitro studies suggested a trend towards anti-inflammatory effects of the conditioned medium, but these findings were not replicated in vivo . Control experiments on healthy eyes indicated that intravitreal trauma alone significantly contributed to inflammatory responses, irrespective of the substance injected. Intravitreal application of mesenchymal stem cell by-products did not demonstrate therapeutic benefits in the experimental autoimmune uveitis model and instead promoted inflammation. The results highlight the impact of administration-induced trauma and suggest that alternative delivery methods, such as systemic administration, may be more effective for mesenchymal stem cell-based therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

UveitisMesenchymal Stem CellsAutoimmune DiseasesMesenchymal Stem Cell TransplantationAnimalsMice, Inbred C57BLIntravitreal InjectionsMiceCulture Media, ConditionedDisease Models, AnimalInflammation

Stichwörter der Autor:innen

MSC-derived exosomesconditioned mediumexperimental autoimmune uveitis (EAU)intravitreal administrationmesenchymal stem cells (MSCs)

Substanzen

Culture Media, Conditioned

Autor:innen und Institutionen

  • Department of Ophthalmology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
  • Department of Toxicology and Molecular Epidemiology, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czech Republic.
  • Department of Ophthalmology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic. Jarmila.Heissigerova@vfn.cz.

Förderung

  • Grantová Agentura, Univerzita Karlova
  • Univerzita Karlova v Praze
  • Ministerstvo Zdravotnictví Ceské Republiky

Zitieren

APA

Uherková, E., Palacká, K., Škrlová, E., Heřmánková, B., Klímová, A., Svozílková, P., Holáň, V., & Heissigerová, J. (2026). Intravitreal Application of Mesenchymal Stem Cell By-Products Does Not Ameliorate Experimental Autoimmune Uveitis. Folia Biologica, 72(2), 95-108. https://doi.org/10.14712/fb2026.0010

Vancouver

Uherková E, Palacká K, Škrlová E, Heřmánková B, Klímová A, Svozílková P, et al. Intravitreal Application of Mesenchymal Stem Cell By-Products Does Not Ameliorate Experimental Autoimmune Uveitis. Folia Biologica. 2026;72(2):95-108. doi:10.14712/fb2026.0010

BibTeX
@article{Uherkov2026,
  author = {Uherková, Eva and Palacká, Kateřina and Škrlová, Eva and Heřmánková, Barbora and Klímová, Aneta and Svozílková, Petra and Holáň, Vladimír and Heissigerová, Jarmila},
  title = {Intravitreal Application of Mesenchymal Stem Cell By-Products Does Not Ameliorate Experimental Autoimmune Uveitis},
  journal = {Folia Biologica},
  year = {2026},
  volume = {72},
  number = {2},
  pages = {95--108},
  doi = {10.14712/fb2026.0010}
}
Kostenlos starten →